Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 475102-10-4 | MDL No. : | MFCD08056374 |
Formula : | C14H14N2O2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | OYPSWAHXXPMBGM-UHFFFAOYSA-N |
M.W : | 242.27 | Pubchem ID : | 7213332 |
Synonyms : |
|
Num. heavy atoms : | 18 |
Num. arom. heavy atoms : | 9 |
Fraction Csp3 : | 0.29 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 68.86 |
TPSA : | 55.02 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | Yes |
CYP2C9 inhibitor : | Yes |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.65 cm/s |
Log Po/w (iLOGP) : | 2.89 |
Log Po/w (XLOGP3) : | 2.99 |
Log Po/w (WLOGP) : | 3.3 |
Log Po/w (MLOGP) : | 1.96 |
Log Po/w (SILICOS-IT) : | 2.09 |
Consensus Log Po/w : | 2.64 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.4 |
Solubility : | 0.0969 mg/ml ; 0.0004 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.81 |
Solubility : | 0.0376 mg/ml ; 0.000155 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.45 |
Solubility : | 0.086 mg/ml ; 0.000355 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.12 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
96% | Stage #1: With dmap In tetrahydrofuran at 20℃; for 0.5 h; Stage #2: for 2 h; |
In a 100 mL round-bottom flask was placed 1H-INDOLE-5-CARBONITRILE (2.0 g, 14.07 MMOL) in 20 mL of anhydrous THF. To this solution was added DMAP (0.86 g, 7.03 MMOL) and the mixture was allowed to stir for 0.5 h at rt. At this point, BOC20 (3.07 g, 14.07 MMOL) was added and the reaction stirred for an additional 2 h. The reaction was then quenched with water and extracted twice with ethyl ether. The combined organic layers were washed successively with 1 N HCI, water, and brine, then dried over MGS04 and concentrated to provide 3.26 g (96percent) of the desired product as a white SOLID.APOS;H- NMR (DMSO-d6) 8 8.20-8. 14 (m, 2H), 7.83 (d, 1H), 7.70 (d, 1H), 6.80 (d, 1H), 1.63 (s, 9H). |
96% | Stage #1: With dmap In tetrahydrofuran at 20℃; for 0.5 h; Stage #2: for 2 h; |
In a 100 ml round-bottom flask was placed 1W-indole-5-carbonitrile (2.0 g, 14.07mmol) in 20 ml of anhydrous THF. To this solution was added DMAP (0.86 g, 7.03mmol) and the mixture was allowed to stir for 0.5 h at rt. At this point, BocaO (3.07 g,14.07 mmol) was added and the reaction stirred for an additional 2 h. The reaction wasthen quenched with water and extracted twice with ethyl ether. The combined organiclayers were washed successively with 1N HCI, water, and brine, then dried over MgSO4and concentrated to provide 3.26 g (96percent) of the desired product as a white solid. 1H-NMR (DMSO-c/e) 5 8.20-8.14 (m, 2H), 7.83 (d, 1H), 7.70 (d, 1H), 6.80 (d, 1H), 1.63 (s,9H). |
90% | With dmap In acetonitrile at 20℃; for 0.5 h; | [0486] tert-butyl 5-cyano-l H-indole-1 -carboxylate (INT-65) [0487] To a flask containing 5-cyanoindole (500 mg, 3.52 mmol) in CH3CN (5 mL) was added Boc20 (920 mg, 4.22 mmol) and DMAP (42 mg, 0.35 mmol) and the mixture was stirred at room temperature for 0.5 h. The mixture was concentrated, redissolved in DCM and chromatographed (EtOAc / hexanes) to provide 766 mg (90percent) of tert-butyl 5-cyano-lH- indole-l-carboxylate INT -65 as a white solid. LCMS-ESI (m/z) calculated for C14H14N20 :242.27; found 243.1 [M+H]+, tR = 3.93 min. |
[ 288251-85-4 ]
tert-Butyl 4-(4-amino-2-cyanophenyl)piperazine-1-carboxylate
Similarity: 0.89
[ 219508-62-0 ]
tert-Butyl 6-amino-1H-indole-1-carboxylate
Similarity: 0.89
[ 279255-90-2 ]
tert-Butyl 5-(hydroxymethyl)-1H-indole-1-carboxylate
Similarity: 0.86
[ 354587-72-7 ]
tert-Butyl 6-(hydroxymethyl)-1H-indole-1-carboxylate
Similarity: 0.86
[ 288251-85-4 ]
tert-Butyl 4-(4-amino-2-cyanophenyl)piperazine-1-carboxylate
Similarity: 0.89
[ 864685-26-7 ]
tert-Butyl 5-cyano-3-iodo-1H-indole-1-carboxylate
Similarity: 0.82
[ 333986-52-0 ]
1-Boc-4-[(4-cyanophenyl)amino]-piperidine
Similarity: 0.81
[ 791846-40-7 ]
tert-Butyl 4-(4-bromo-2-cyanophenyl)piperazine-1-carboxylate
Similarity: 0.76
[ 288251-87-6 ]
tert-Butyl 4-(2-cyano-4-nitrophenyl)piperazine-1-carboxylate
Similarity: 0.73
[ 219508-62-0 ]
tert-Butyl 6-amino-1H-indole-1-carboxylate
Similarity: 0.89
[ 279255-90-2 ]
tert-Butyl 5-(hydroxymethyl)-1H-indole-1-carboxylate
Similarity: 0.86
[ 354587-72-7 ]
tert-Butyl 6-(hydroxymethyl)-1H-indole-1-carboxylate
Similarity: 0.86
[ 864685-26-7 ]
tert-Butyl 5-cyano-3-iodo-1H-indole-1-carboxylate
Similarity: 0.82